fetal-echo.org · Clinical Series · High Cardiac Output

When the Fetal Heart
Is Drowning in Volume

A structured clinical guide to recognising, monitoring, and timing intervention in fetal high cardiac output states.

~1 L Normal CCO at 32 weeks
Elevation in severe AVM
800 ml/kg/min danger threshold
↓ scroll
Background

The Heart Is Not the Disease — It Is the Victim

High cardiac output in the fetus is not a diagnosis. It is a physiological state with a cause, a trajectory, and a window of action. All causes share the same mechanism: an additional low-resistance vascular pathway forces the fetal heart to generate far more output than it was built to sustain.

The fetal myocardium differs fundamentally from the postnatal heart. It operates near maximum sarcomere length at baseline, has limited Frank-Starling reserve, and depends heavily on heart rate as its primary compensatory tool. When that reserve is exhausted — the decompensation can be rapid.

This guide covers the recognition, monitoring framework, and gestational-age-specific decision thresholds for high-output fetal cardiac states.

Key Concept
At 32 weeks, a normal fetus pumps approximately 1 litre per minute. This is your anchor. Double is significant. Triple is serious. Five times is extreme. You do not need a calculator to know that a VTI of 25 cm at 32 weeks — against a normal of 13 cm — is a significant finding.
Aetiology

Causes and Their Cardiac Output Range

Click each condition to expand its key features.

Fetal high cardiac output causes — anatomical overview showing CCO ranges by condition
Fig 1. Causes of fetal high cardiac output mapped to anatomical location. CCO ranges shown in indexed ml/kg/min. Note peripheral AVM can exceed all others despite appearing small on ultrasound — resistance, not size, determines output.

AV Malformation

565–1,700+ ml/kg/min

Cerebral, hepatic, or peripheral. Output driven by resistance — not lesion size.

Sacrococcygeal Teratoma

750–1,500+ ml/kg/min

Thousands of microfistulae. Output tracks tumour growth predictably.

Placental Chorioangioma

600–1,000 ml/kg/min

AV shunting within placental mass. Resolves at birth with placental delivery.

Arteriovenous Malformation — Key Features

Shunt architecture
One or few large direct AV fistulae — high individual flow per fistula
Output determinant
Shunt resistance, not lesion size. A small peripheral AVM with very low resistance can generate CCO >5× normal.
Speed of deterioration
Can be abrupt — resistance may drop suddenly without warning
Monitoring surrogate
VTI trend + DV A-wave + heart rate trend as chronotropic marker
Postnatal crisis risk
High — AVM persists after delivery; placental buffer removed at cord cutting
Postnatal intervention
Embolisation (cerebral) or surgical ligation (peripheral) — timing depends on cardiac stability
Genetics
RASA1, EPHB4 (CM-AVM), HHT (ENG, ACVRL1). Family history of telangiectasia or nosebleeds is essential to ask.
Key distinguishing feature
Brain steal (cerebral AVM); liver dysfunction (hepatic); systemic redistribution (peripheral)

Sacrococcygeal Teratoma — Key Features

Shunt architecture
Thousands of microfistulae throughout growing tumour — low flow per fistula, high aggregate
Output determinant
Tumour size and vascularity. Output grows proportionally with tumour bulk.
Speed of deterioration
Gradual and more predictable — tracks tumour growth week to week
Monitoring surrogate
Tumour vascularity index + CCO + DV waveform
Postnatal crisis risk
Moderate — tumour removed at surgery; cardiac function recovers if not already failed
Postnatal intervention
Surgical resection — urgent if cardiac failure present; elective if stable
Fetal intervention
Possible at specialist centres — interstitial laser ablation, open fetal surgery for selected cases
Key complication
Tumour haemorrhage; polyhydramnios; Ballantyne (mirror) syndrome

Placental Chorioangioma — Key Features

Shunt architecture
Multiple vascular channels within placental mass — intermediate architecture
Output determinant
Lesion size and vascularity — colour Doppler vascularity index correlates with shunt
Speed of deterioration
Moderate — correlates with lesion growth; generally more gradual than AVM
Monitoring surrogate
Lesion size + CCO + DV waveform + MCA PSV if anaemia suspected
Postnatal crisis risk
Low — placenta delivered; shunt source removed at birth
Postnatal intervention
None needed — condition resolves with placental delivery
Associated complication
Fetal anaemia (microangiopathic); polyhydramnios; Ballantyne syndrome
Key distinguishing feature
Best prognosis of the three if managed antenatally — the shunt disappears at birth
The Key Distinguishing Principle
In AVM — output is driven by resistance, not size. In SCT — output tracks tumour bulk. In chorioangioma — the shunt resolves at birth. The postnatal prognosis is therefore fundamentally different across these three conditions even when the antenatal CCO is similar.
Quantification

CCO Thresholds — What the Numbers Mean at 32 Weeks

The gauge below shows indexed CCO ranges and their clinical significance. The danger threshold — above which decompensation risk climbs steeply — sits at 750–800 ml/kg/min.

DANGER THRESHOLD ~340 Normal 430–640 Mildly elevated 640–1,070 Significantly elevated 1,070–1,430 Severely elevated >1,430 Extreme ~1,750 5× Normal ml/kg/min
THE DANGER THRESHOLD
Most published series identify indexed CCO above 750–800 ml/kg/min as the zone where cardiovascular instability, hydrops, and in-utero demise risk increases significantly. Above this level, the probability of decompensation climbs steeply.
CCO at 32 weeks (absolute)Indexed (~2.8 kg)InterpretationClinical state
~950 ml/min~340 ml/kg/minNormalNormal
1,200–1,800 ml/min~430–640 ml/kg/minMildly elevatedCompensated Monitor closely
1,800–3,000 ml/min~640–1,070 ml/kg/minSignificantly elevatedEscalate Twice weekly echo
3,000–4,000 ml/min~1,070–1,430 ml/kg/minSeverely elevatedEscalate Myocardial fatigue expected
>4,000 ml/min>1,430 ml/kg/minExtremeCritical Narrow margin to decompensation
Quantification

The Shunt Fraction — Making the Burden Visible

In any high-output state, the extra cardiac output above normal is going into the shunt. Expressing this as a fraction of total output makes the physiological burden immediately clear — and is more intuitive than indexed CCO alone.

Actual CCO 4,900 ml/min 80% The Shunt (AVM) 20% Brain, Kidneys, Gut FORMULA (4,900 – 950) ÷ 4,900 = 80%
⚠ Above 50%
Significant redistribution. More than half of cardiac output is not reaching normal end-organs.
⚠ Above 70%
Critical alert. Immediate risk regardless of whether DV or hydrops changes have appeared yet.
Monitoring

Echo Parameters to Track — In Priority Order

No single parameter makes the management decision. The decision is made by watching multiple parameters move in the same direction, over time, in the context of gestational age.

Parameter
What to track
Danger signal
1
Ductus venosus A-wave
Forward → absent → reversed
Any reversal = right heart pressure critical
2
Biventricular VTI trend
Rising or stable vs falling
Falling VTI = decompensation, not improvement
3
Fetal heart rate trend
Was it higher before? Is it falling?
Rate falling in high-output state = chronotropic fatigue
4
MPI (Tei index)
Serial values — is it rising?
MPI >0.58–0.65 = significant myocardial inefficiency
5
Serous effusions
Pericardial → pleural → ascites
Ascites = overt hydrops; delivery discussion
6
CTR trend
Serial measurements
CTR >0.50 = cardiomegaly; >0.55 = reserve exhausted
7
CCO absolute value
Calculate formally at each visit
CCO >3× normal for gestation = severely elevated
8
UV pulsatility
Present or absent
Any pulsatility = transmitted right heart failure; late sign
The VTI Paradox
A VTI that was previously elevated and begins to fall might seem reassuring — as if the heart is doing less work. This interpretation is wrong. A falling VTI in a previously high-output fetus means the heart can no longer sustain the elevated output. Treat a downward VTI trend as a decompensation signal, not as improvement.
Scoring

The Cardiovascular Profile Score — With Its Limitation in High-Output States

The CVPS provides a structured single-number summary of fetal cardiac compromise across five domains. Use the interactive calculator below, then read the important caveat for high-output states.

Score each domain — 2 (normal), 1 (mild), 0 (severe)
Hydrops
2 = no effusions · 1 = single effusion · 0 = two or more / skin oedema
Venous Doppler
2 = normal DV + UV · 1 = absent DV A-wave or UV pulsatility · 0 = reversed DV A-wave
Heart Size (CTR)
2 = CTR <0.35 · 1 = CTR 0.35–0.50 · 0 = CTR >0.50 or decreased size
Cardiac Function
2 = normal, no TR · 1 = mild dysfunction / mild TR / elevated MPI · 0 = severe dysfunction / severe TR
Arterial Doppler
2 = normal UA + isthmus · 1 = absent UA EDF · 0 = reversed UA flow / retrograde isthmus
Total CVPS
out of 10
CVPS Domains Over Time — High-Output State 0.70 0.65 0.55 0.45 0.40 Heart Size (CTR) Normal Normal Reversed Venous Doppler (DV) Time / Progression of Failure → Placental Buffering Window Heart Size (CTR) — drops early Venous Doppler (DV) — holds long
THE CVPS LIMITATION
CVPS was developed for immune/non-immune hydrops — not high-output states specifically.
THE MECHANISM
Heart size drops first. Venous Doppler holds normal much longer because placental buffering delays right heart pressure rise.
THE CLINICAL RULE
The score can underestimate risk. Always interpret CVPS alongside absolute CCO.
Decision Framework

Approach by Gestational Age

The same echo findings carry different weight at different gestational bands. Tap each band to expand the clinical approach.

20–26 wk Diagnose & Baseline
Key Actions
  • Full structural fetal echo — exclude concurrent cardiac lesions
  • Establish baseline CCO, MPI, CTR, VTI — all future scans compared to this
  • Full venous Doppler survey at every visit
  • Fetal MRI where anatomy requires it (VOGM, complex hepatic AVMs)
  • Anaemia screen — MCA PSV ≥1.5 MoM
  • Genetic counselling if HHT or CM-AVM syndrome suspected
Thresholds
  • Delivery threshold is very high at this gestation
  • Hydrops before 24 weeks carries very poor prognosis — counsel thoroughly
  • IUT if MCA PSV >1.5 MoM and anaemia confirmed
Monitoring interval: Weekly if compensated. Every 3–4 days if any venous Doppler change or early hydrops.
26–30 wk Watchful Escalation
Key Actions
  • DV waveform is your primary decision trigger at every visit
  • Track MPI trend across scans — rising MPI precedes venous changes
  • Watch for pericardial effusion — first serous cavity signals onset of failure
  • Antenatal steroids if delivery before 34 weeks becomes realistic
  • Brief NICU and neonatal cardiology now — not during a crisis
Thresholds
  • Delivery is a last resort — viability established but prematurity risk very high
  • Overt hydrops = emergency MDT regardless of gestation
  • DV A-wave absence = inpatient monitoring
Monitoring interval: Twice weekly. Every 2–3 days with pericardial effusion or MPI elevation.
30–34 wk The Decision Window ⚠
Key Actions
  • DV A-wave status at every single scan — document explicitly
  • Heart rate trend is now a primary parameter — is it falling?
  • VTI plateau or decline — document trajectory not single value
  • Serous fluid inventory — pericardial, pleural, ascites
  • Steroids must be administered
  • Delivery centre must have L3 NICU + paediatric cardiology + IR on standby
Thresholds
  • Target delivery at 34 weeks if stable
  • Deliver earlier if DV reversal, ascites, HR falling, or VTI dropping
  • DV absent A-wave = inpatient; DV reversal = deliver within 24–48 h
Monitoring interval: Twice weekly minimum. Three times weekly with any decompensation marker. Inpatient if DV A-wave absent.
34–37 wk Planned Delivery
Key Actions
  • Plan delivery at 34–35 weeks with any decompensation marker
  • Do not wait for a crisis at this gestation — the marginal gain from each additional week is smaller than the risk
  • Confirm intervention team readiness before delivery date
  • Delivery room echo plan — postnatal assessment within first hour
  • Umbilical venous access plan at delivery
Thresholds
  • Postnatal intervention is substantially more feasible at this gestation
  • Vessel calibre larger, anaesthetic risk lower, blood volume more tolerant
  • If completely stable with normal DV — can consider extending to 36–37 weeks
Monitoring interval: Twice weekly. Plan delivery date proactively — not reactively.
≥37 wk Deliver

There is no fetal benefit to continuing beyond term in a high-output state. Deliver and optimise postnatal management.

Action: Deliver. Postnatal echo within the first hour of life. Intervention team ready. Umbilical venous access at delivery.
Escalation

Red Flags — Immediate MDT Action Required

Regardless of gestational age, any of the following findings should prompt same-day reassessment and urgent MDT discussion.

DV A-wave reversed
Right atrial pressure critical.
Deliver within 24–48 h if >28 weeks; immediate MDT.
UV pulsatility develops
Transmitted right heart failure (late sign).
Immediate MDT; delivery planning same day.
New ascites
Overt hydrops — decompensation complete.
Deliver if viable.
Falling VTI
Heart can no longer sustain output.
Escalate immediately. Do not misinterpret as improvement.
HR < 120 bpm
Chronotropic fatigue — autonomic reserve exhausted.
Increase monitoring; brief delivery team.
CTR > 0.55
Severe cardiomegaly.
Reassess delivery threshold urgently.
MPI > 0.65
Significant myocardial inefficiency.
Review delivery plan.
Pleural effusion
Escalating hydrops — second cavity involved.
Delivery discussion if >32 weeks.
Team-Based Care

The MDT Is Not Optional

High-output fetal cardiac states cannot be managed by the fetal cardiologist alone. The decisions made at 30–34 weeks require advance coordination across multiple teams. A decision made in advance is always safer than one made at 2am when the DV reverses.

Minimum MDT Composition
Fetal cardiologist · Maternal-fetal medicine / high-risk obstetrics · Neonatology (Level 3 NICU) · Paediatric interventional radiology or vascular surgery · Paediatric cardiac anaesthesia · Postnatal paediatric cardiology team

The MDT must pre-agree three things in writing — before any crisis occurs:

01
Target delivery gestation
Agreed in advance — so this decision is not made under pressure at 2am.
02
Specific delivery triggers
Written, documented, and shared with all teams before the event.
03
Postnatal intervention plan
Who does what, when, and what the fallback is if the neonate does not stabilise.
Summary

Five Principles to Close With

  1. Calculate CCO formally at least once per case. Use it as your personal baseline — every subsequent scan tells you if the number is rising or falling. At 32 weeks, normal is 1 litre per minute. Five times that is extreme.
  2. A CCO more than double the expected for gestation is significant. More than triple is serious. More than five times is extreme. This is the frame that makes CCO clinically intuitive at the bedside.
  3. The DV A-wave is your earliest and most reliable pressure gauge. Track it at every visit. A falling heart rate in a high-output fetus is not stability — it is chronotropic fatigue.
  4. A falling VTI in a previously high-output fetus is decompensation, not improvement. The descending limb of the Starling curve in an overloaded heart. Treat it as urgent — always.
  5. Decisions made in advance by a prepared MDT are safer than decisions made in crisis. Brief the team before the DV reverses — not after.
"The CVPS tells you where the fetus is on the map.
The CCO tells you how fast it is moving toward the edge."